Cargando…

Renal flare as a biomarker of incident and progressive chronic kidney disease in patients with lupus nephritis

Detalles Bibliográficos
Autores principales:	Parikh, S, McKinley, A, Rovin, BH
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467522/ http://dx.doi.org/10.1186/ar3979

Ejemplares similares

Cytokine profiles of lupus patients with or without nephritis
por: Rovin, BH, et al.
Publicado: (2012)

Molecular characterization of proliferative lupus nephritis
por: Parikh, Samir V, et al.
Publicado: (2014)

Characterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-responders
por: Parikh, Samir V, et al.
Publicado: (2015)

Methodological quality of studies of end-stage renal disease risks in lupus nephritis
por: Tektonidou, Maria, et al.
Publicado: (2014)

Time to lupus nephritis: impact of gender and ethnicity
por: Seligman, VA, et al.
Publicado: (2001)

Contemporary estimates of the risk of end-stage renal disease in the first decade of proliferative lupus nephritis
por: Ward, MM, et al.
Publicado: (2012)

Value of repeat biopsy in lupus nephritis flares
por: Greloni, G, et al.
Publicado: (2014)

The value of repeat biopsy in lupus nephritis flares
por: Narváez, Javier, et al.
Publicado: (2017)

The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its Flare
por: Toy, Chris R., et al.
Publicado: (2021)

Usual source of care and geographic region are largest predictors of healthcare quality for incident lupus nephritis in US Medicaid recipients
por: Yazdany, J, et al.
Publicado: (2012)

Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV
por: Hanaoka, Hironari, et al.
Publicado: (2018)

Effect of Belimumab on Preventing de novo Renal Lupus Flares
por: Parodis, Ioannis, et al.
Publicado: (2023)

Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention
por: Banos, Aggelos, et al.
Publicado: (2023)

Differing environmental risk factors for membranous versus proliferative lupus nephritis
por: Dooley, MA, et al.
Publicado: (2012)

Serum chemokine levels predict flares of disease activity in two independent systemic lupus erythematosus cohorts
por: Bilgic, H, et al.
Publicado: (2012)

Variation in renal biopsy and medication prescribing practices among pediatric Medicaid patients with lupus nephritis prior to end-stage renal disease in the US, 2000 to 2004
por: Hiraki, LT, et al.
Publicado: (2012)

Sociodemographics and epidemiology of serious infections requiring hospitalization among adults with systemic lupus erythematosus and lupus nephritis, 2000 to 2006
por: Feldman, Candace H, et al.
Publicado: (2014)

Lupus nephritis flare in young patients: relapse or nonadherence to treatment?
por: Rivera, Francisco, et al.
Publicado: (2014)

Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis
por: Clark, Marcus R, et al.
Publicado: (2014)

Renal and Inflammatory Proteins as Biomarkers of Diabetic Kidney Disease and Lupus Nephritis
por: Johnson, Nathan H., et al.
Publicado: (2022)

Expression and regulation of discoidin domain receptor 1 (DDR1) – a novel receptor for collagen – in normal human renal cells and patients with lupus nephritis
por: Boumpas, DT, et al.
Publicado: (2003)

Thinking toward improved treatments of systemic lupus erythematosus
por: Hahn, BH, et al.
Publicado: (2012)

The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States
por: Bell, Christopher F, et al.
Publicado: (2022)

Identification of stage-specific genes associated with lupus nephritis and response to remission induction in NZB/W and NZM2410 mice
por: Bethunaickan, Ramalingam, et al.
Publicado: (2014)

Low-Grade Proteinuria Does Not Exclude Significant Kidney Injury in Lupus Nephritis
por: De Rosa, Marcelo, et al.
Publicado: (2020)

WCN23-0359 RENAL FLARE IN ADOLESCENTS WITH LUPUS NEPHRITIS RECEIVED COVID-19 mRNA VACCINE
por: THEPVEERA, S., et al.
Publicado: (2023)

Renal function and biomarkers of acute kidney injury in pediatric patients
por: Málaga, Serafín
Publicado: (2015)

In situ cognate interactions between T-follicular helper cells and B cells characterize severe tubulointerstitial inflammation in human lupus nephritis
por: Clark, MR, et al.
Publicado: (2012)

Expanding the Role of Complement Therapies: The Case for Lupus Nephritis
por: Li, Nicholas L., et al.
Publicado: (2021)

Patient-Centered Outcomes Research Institute (PCORI) multisite project to develop treatment decision aids for racial/ethnic minorities with lupus nephritis
por: Yazdany, Jinoos, et al.
Publicado: (2014)

Preliminary population-based incidence and prevalence estimates of systemic lupus erythematosus: the California Lupus Surveillance Project
por: Dall'Era, Maria C, et al.
Publicado: (2014)

Discovery of NEU1 as a candidate renal biomarker for proliferative lupus nephritis chronicity
por: Mao, Zhaomin, et al.
Publicado: (2021)

mTOR activation triggers proinflammatory expansion of IL-4-producing and necrosis-prone double-negative T cells, precedes flares, and serves as target for treatment in patients with systemic lupus erythematosus
por: Lai, Zhi-Wei, et al.
Publicado: (2014)

Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022)

Rethinking Lupus Nephritis Classification on a Molecular Level
por: Almaani, Salem, et al.
Publicado: (2019)

Kidney disease in lupus is not always 'lupus nephritis'
por: Anders, Hans-Joachim, et al.
Publicado: (2013)

Biomarker Profiling for Lupus Nephritis
por: Li, Yajuan, et al.
Publicado: (2013)

Urinary biomarkers in lupus nephritis
por: Aragón, Cristian C., et al.
Publicado: (2020)

A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis
por: Parikh, Samir V., et al.
Publicado: (2021)

Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE
por: Gilbert, Mileka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5senjj5l1fmut6j2vg6npi5gbl